WATD and Cancer-Related Fatigue: A Study For Patients Undergoing Anti-Cancer Treatment

This study is investigating whether a wearable activity-tracking device (WATD) — which monitors movement and activity — can help measure and manage cancer-related fatigue in people undergoing cancer treatment. Fatigue is one of the most common and disruptive side effects of cancer therapy. **You may be eligible if...** - You have pancreatic cancer or invasive breast cancer - You are currently receiving or planning to start anti-cancer treatment - You have any level of self-reported fatigue - You are 18 or older - You can read and understand English **You may NOT be eligible if...** - You have a medical condition that the investigator believes would interfere with using the wearable device or completing questionnaires - You are not planning to receive anti-cancer treatment Talk to your doctor to see if this trial is right for you.